ANN ARBOR, Mich. and AUSTIN, Texas, March 9, 2026 /PRNewswire/ -- One Intelligence ( 1-i.ai ) today announced the launch of its AI Control Plane, a unified platform designed to help enterprises build, ...
By Tarun Sai Lomte A large cross-sectional study of Japanese adults with type 2 diabetes reveals that alcohol intake may ...
Context Blood flow-restricted resistance exercise (BFR-RE) is used to elicit hypertrophy and strength adaptations with low external loads, making it attractive for clinical and rehabilitative ...
By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...
The combination strategy is designed to simultaneously block proliferative signaling through RAS inhibition and disrupt tumor survival pathways via elraglusib’s GSK-3ß inhibition, potentially ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
Domain adaptation may be a novel creative solution to predict infection risk in patients with chronic lymphocytic leukemia ...
SkinJect Inc., a wholly owned subsidiary of Medicus Pharma Ltd., is a development-stage life sciences company focused on commercializing a novel, non-invasive treatment for basal cell skin cancer ...